Cargando…
Worsening of asthma control after COVID-19
BACKGROUND: SARS-CoV-2 enters lung cells via angiotensin-converting enzyme 2 (ACE2) receptor. Several studies suggest that interleukin-13, an important cytokine involved in T2 inflammation, reduces ACE2 expression, and therefore, asthma would not be a significant risk factor for the development of s...
Autores principales: | Agondi, Rosana Câmara, Menechino, Natália, Marinho, Ana Karolina Barreto Berselli, Kalil, Jorge, Giavina-Bianchi, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524244/ https://www.ncbi.nlm.nih.gov/pubmed/36186769 http://dx.doi.org/10.3389/fmed.2022.882665 |
Ejemplares similares
-
293 Sensitization of Severe Allergic Asthma Patients
por: Takejima, Priscila, et al.
Publicado: (2012) -
315 Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough
por: Agondi, Rosana Camara, et al.
Publicado: (2012) -
Difficult‐to‐control asthma management through the use of a specific protocol
por: Giavina‐Bianchi, Pedro, et al.
Publicado: (2010) -
Debate on drugs that may aggravate COVID-19
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2020) -
Comorbidities in Severe Asthma: Frequency of Rhinitis, Nasal Polyposis, Gastroesophageal Reflux Disease, Vocal Cord Dysfunction and Bronchiectasis
por: Bisaccioni, Carla, et al.
Publicado: (2009)